Infertility
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who meet the above-mentioned diagnostic criteria of Chinese and Western medicine, aged 20-38 years old, have been diagnosed with stage III and IV endometriosis through laparoscopic surgery, and are planning to undergo IVF-ET for fertility at a reproductive center; (2) Have not received traditional Chinese medicine, hormones and similar treatments for at least 3 months before enrollment; (3) Be able to receive oral treatment with Chinese medicine and voluntarily cooperate with relevant inspections; (4) Informed consent to this study and signed informed consent form. (5) Receive random grouping and take drugs according to the study protocol.
Exclusion criteria
Exclusion criteria: (1) Those with genital tract malformations, uterine submucosal fibroids, and intrauterine adhesions found by hysteroscopy; (2) Patients with adenomyosis and hydrosalpinx; (3) The woman whose endocrine test is abnormal; (4) Other abnormal immune antibodies; (5) The man with severe oligospermia; (6) Those who have had immunotherapy or used immune function regulating drugs in the past 3 months; (7) Those who have a history of autoimmune diseases and/or other medical and surgical diseases; (8) Patients with cardiovascular and cerebrovascular diseases, severe primary diseases of the liver, kidney, and hematopoietic system and mental illnesses.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Abortion rate;Embryo implantation rate;Live birth rate;Pregnancy rate;Clinical pregnancy rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Biochemical factor detection;Endometrial receptivity test;Serum hormone determination;Oocyte and embryo grade evaluation; | — |
Countries
China
Contacts
Guangdong Hospital of Traditional Chinese Medicine